In previous reports (1, 2) we demonstrated that Toxoplasma gondii, an obligate intracellular parasite, is susceptible to oxygen intermediates generated by the partial reduction of molecular oxygen. In a cell-free model, toxoplasmas are resistant to superoxide anion (O~-) and hydrogen peroxide (H202), but are readily killed by toxic products of O~-H202 interaction, presumably hydroxyl radical (OH-) and singlet oxygen (102) (1). We also implicated these latter two oxygen intermediates as probable mediators of the toxoplasmastatic and toxoplasmacidal activity of specifically immune peritoneal macrophages (2).
viable Pasteur type Bacille Calmette-Gu~rin (BCG) (Trudeau Institute, Saranac Lake, N. Y.) or 0.2 ml (1.4 mg) of formalin-killed Co~ynebaeterium parvum (Coparvax; The Wellcome Research Laboratories, Kent, England). Macrophages were harvested 1-3 wk later from intraperitoneal BCG-infected mice (3), 3-4 wk later from intravenous BCG-infected mice, and after 1-3 wk for (7. parvum-immunized mice. In addition, some animals were boosted intraperitoneally with respective antigen (2 × 107 autoclaved BCG or 1.4 mg of C. paroum) 3 d before harvest.
Macrophages were also obtained from NCS mice 4 d after intraperitoneal injection of 1 ml of phosphate-buffered saline (PBS)~containing I% proteose peptone (PP), 4% Brewer's thioglycollate (THIO), or 1% heart infusion (HIB) broths, all from Difco Laboratories, Detroit, Mich. Additional macrophages (provided by Dr. V. Freedman, The Rockefeller University) were from C57BL/6J mice injected intraperitoneally 3-4 wk before with 2 × 107 heat-killed BCG, and boosted intraperitoneally with dead BCG 4 d before harvest.
Macrophage Cultivation. Peritoneal cells were harvested by the method of Cohn and Benson (4). 4-5 × l0 b cells, suspended in Dulbecco's modified Eagle's medium containing 20% heatinactivated fetal bovine serum (FBS) (HIFBS), 100 U/ml penicillin and 100 #g/ml streptomycin (D~HIFBS), were added directly to 12 mm-round glass cover slips. Coverslips were placed in 35-mm plastic tissue culture dishes (Nunclon, Roskilde, Denmark) for toxoplasma infection experiments, or in 16-ram wells of tissue culture trays (Costar, Data Packaging, Cambridge, Mass.) for H202 and O~-assays. After 60 min at 37°C in 5% CO2, nonadherent cells were removed by washing and cultures were reincubated for up to 72 h before infection or assay in D20HIFBS alone or in D20HIFBS plus spleen cell supernates. Fresh media were added daily. After 24 h in culture, polymorphonuclear leukocytes accounted for < 1% of adherent cells for all macrophage populations.
P~e~aration of Mitogen-and Antigen-Stimulated Spleen Cell Supernates (Lymphokines). l0 s cells (1.7
× 10/ml) from spleens of (a) toxoplasma immune mice, (b) mice infected intravenously with BCG, or (c) normal mice were incubated with (a) 300/~g (50/~g/ml) of toxoplasma frozenthawed antigen (2), (b) 1 × 10 v (1.7 × 106/ml) autoclaved BCG, or (c) 3/~g/ml ofconeanavalin A (Con A) (Miles Laboratories Inc., Elkhart, Ind.), respectively, for 48 h at 37°C in 5% CO2. In addition, each 6-ml culture contained Dulbecco's medium with 2% FBS, penicillin, and streptomycin. Control supernates consisted of cultures of spleen cells from normal mice incubated for 48 h with (a) toxoplasma antigen, (b) autoclaved BCG, or (c) alone, with Con A added at the end of the cultivation period. Collected supernates were centrifuged at 500 g for 20 rain, sterilized by filtration, and stored at -70°C. Just before use, supernates were thawed and diluted in D2oHIFBS as follows: toxoplasma 1:20 (5%), BCG 1:8 (12.5%), and Con A 1:4 (25%) (5) .
Macrophage Antitoxoplasma Activity. 1 ml of D20HIFBS with 1-2 × 106 viable toxoplasmas was added for 30 min to dishes containing cover slips, followed by washing and reincubation in fresh medium. At various intervals, duplicate cover slips were fixed, stained, and counted microscopically as described (2) . Killing of intracellular toxoplasmas (microbicidal activity) was indicated by a decrease in both the percent of cells infected and in the number of toxoplasmas/ 100 macrophages, whereas failure of parasites to replicate as judged by the number of toxoplasmas/vacuole 18 h after infection indicated microbistatic activity. Resident macrophages from normal mice fail to kill or inhibit the multiplication of viable T. gondii, and 18 h after infection there are four to five toxoplasmas/vacuole. In contrast, IM macrophages inhibit parasite replication for 24-30 h, and IB cells display potent toxoplasmacidal activity (2) . The latter macrophages also appear strikingly activated morphologically with circumferential spreading, pronounced plasma membrane ruffling, and increased numbers of lysosomes and vesicles (2) .
Glucose-Free Medium, Oxygen Intermediate. Scavengers, and Other Reagents. Glucose-free medium and scavengers including superoxide dismutase (SOD), catalase, mannitol, benzoate, diazabicyclooctane (DABCO), and histidine were obtained, prepared, and administered to macrophages as previously reported (2) . Glucose oxidase (type V) and xanthine oxidase (milk, 65 mg/ ml) were from Sigma Chemical Co., St. Louis, Mo. Xanthine was prepared in 0.05 M potassium phosphate buffer (pH 7.8) and EDTA (10 -4 M) at 10 -a M.
Assays for HzOe and O~ Release. After various periods of cultivation, cover slips in Costar tray wells were thoroughly washed, and 1.5 ml of Krebs-Ringer phosphate buffer with 5.5 mM glucose, pH 7.4, was added to each well for 90 min at 37°C (water bath). For HzO= release, the 1.5-ml reaction mixture contained scopoletin (Sigma Chemical Co.), 10 nmol/ml, horseradish peroxidase (Sigma Chemical Co., 0.44 purpurogaUin U/ml, and phorbol myristate acetate (PMA) (Consolidated Midland Corp., Brewster, N. Y.), 100 ng/ml (2, 3). For O~-release, each 1.5 ml contained 80 #M ferricytochrome c (Sigma Chemical Co., type VI) and 100 ng/ml PMA (6) . For H~O2, the oxidation of scopoletin by H202 catalyzed by horseradish peroxidase was assayed fluorometrically (3). For O~-, the aspirates were cleared by centrifugation and the concentration of reduced cytochrome c was determined spectrophotometrically using the extinction coefficient AE~0 ,,~ ----2.1 X 104 M -1 cm -1 (6). In the absence of PMA, there was no detectable release of H202 or O~-. The addition of 25 #g/ml of SOD to the O~-assay reaction mixture abolished cytochrome c reduction for all cell types tested. Cell protein was determined by the method of Lowry et al. (7) after treatment of cover slips with 0.5 ml of 0.5 N NaOH. Results are expressed as nanamoles of H202 or O~-released/90 min per microgram of adherent cell protein.
Qualitative Nitroblue Tetrazolium (NBT) Reduction. Cultivated macrophages were exposed for 30 rain at 37°C in 5% CO2 to either 2 X l0 s toxoplasmas or 2 X 106 opsonized zymosan particles suspended in 1 ml of D20HIFBS containing 0.5 mg/ml of NBT (Sigma Chemical Co., grade III). Uningested parasites or particles were removed by washing, and cover slips were reincubated in medium alone for an additional 30 min. Intracellular toxoplasmas and zymosan were identified using phase contrast optics and then viewed by bright field microscopy. Macrophages were scored as positive if ingested parasites or particles were stained blue-black by precipitated formazan, the oxygen-dependent reduction product of NBT (8, 9) .
Results

In Vivo-Activated Macrophages
OXIDATIVE
CAPACITY AND ANTITOXOPLASMA ACTIVITY.
The capacity to generate increased levels of oxidative metabolites appears to underlie the enhanced antitoxoplasma activity of IM and IB macrophages (2) . We explored the general applicability of this biochemical-biologic relationship by examining 12 additional macrophage populations activated in vivo by stimuli unrelated to T. gondii. As judged by extracellular release of H20~ (Fig. 1 Fig. 1 , immunologic specificity was not required for successful activation of macrophages to inhibit toxoplasma multiplication. Intraperitoneal boosting with respective microbial antigen before harvest heightened both oxidative and antimicrobial activity, and as previously reported for toxoplasmaimmune mice (2), converted cells from microbistatic to strongly microbicidal. Intraperitoneal boosting of mice previously injected intraperitoneally (but not intravenously) with C. parvum or dead BCG also resulted in toxoplasmacidal activity if cells were infected shortly after explanting. At this time, however, up to 20% of adherent cells from these mice were polymorphonuclear leukocytes, making interpretation of H202 release difficult. If first cultivated for 24 h before infection, these boosted C: parvum and BCG maerophages displayed only toxoplasmastatic activity ( Fig. 1 ).
Macrophages from nonimmune mice injected intraperitoneally with a boosting dose of dead toxoplasmas 3 d before harvest displayed neither enhanced oxidative capacity nor antitoxoplasma activity.
PRESERVATION OF MORPHOLOGIC, BIOCHEMICAL~ AND ANTIMICROBIAL PROPERTIES OF
THE ACTIVATED STATE BY LYMPHOKINE. If cultivated in standard medium alone, the toxoplasmastatic and toxoplasmacidal activity of IM and IB macrophages, respectively, persists for 48 h and then is abruptly lost (2) . This loss of activity was closely paralleled by a steep decline in oxidative capacity such that by 72 h these cells released no more H202 than resident cells from normal mice (Fig. 2) . By this time, IM and IB macrophages no longer appeared activated morphologically, and closely resembled normal cells (2) . Increased O~" release after PMA triggering also declined during 72 h of cultivation (data not shown). In contrast, daily exposure to as little as 5% fresh toxoplasma lymphokine maintained the enhanced capacity of IM and IB cells to release H202 ( Fig. 2 ) and preserved their in vitro antitoxoplasma activity ( Fig.  3 A) . Control supernate failed to prevent the decline in either of these two functional markers of macrophage activation. Lymphokine-treated ceils also remained activated morphologically, showing circumferential spreading and plasma membrane ruffling. Daily addition of toxoplasma lymphokine after infection of freshly explanted 3-h cultures inhibited the multiplication of the few surviving parasites within IB cells for up to 72 h (2), and partially reversed the loss of IM macrophage toxoplasmastatic activity (Fig. 3 B) .
In Vitro-Activated Macrophages
EFFECT OF LYMPHOKINE ON OXIDATIVE CAPACITY AND ANTITOXOPLASMA ACTIVITY OF NORMAL AND ELICITED MACROPHAGES. In vitro exposure to lymphokines has been reported to induce normal human monocytes and chemically-elicited (but not resident) mouse peritoneal macrophages to inhibit toxoplasma replication (10-13). Lymphocyte products can also activate resident or elicited macrophages to kill other intracellular pathogens such as Leishmania enrietti (14) and T~ypanosoma cruzi (5).
Although exposure to three separate lymphokines (toxoplasma, BCG, Con A) was sufficient to morphologically activate resident and PP-elicited cells (Fig. 4) and to augment their H~O2 release (Fig. 5A ), these cells failed to restrict toxoplasma multiplication. 18 h after infection of macrophages first preincubated with lymphokines for 24-72 h, there were four to five toxoplasmas/vacuole. Further addition of supernates after infection also failed to induce any inhibitory activity. Because products of O~--H202 interaction (e.g., OH. and 102 [15] [16] ) appear to be key toxoplasmacidal oxygen intermediates (2), we next investigated O~-release by in vitro-activated macrophages. A defect in O~-production was not anticipated because most or all H~O2 arises from the dismutation of Of (17) . As illustrated in Fig. 5 , lymphokine-treated normal and PP-elicited cells released comparable amounts of H~O2 and O~-, and threefold more O~ than controls after 72 h.
The possibility that ingested toxoplasmas fail to trigger the oxidative burst of in vitro activated macrophages, and thus are able to replicate by evading injurious oxygen metabolites (8) , was explored using the qualitative NBT test (8, 18) . Normal cells cultivated in standard medium alone or control supernates responded appropriately to zymosan particles, but failed to reduce NBT after phagocytosis of viable toxoplasmas (8) ( Table I and Fig. 6A ). Lymphokine-treated ceils, however, readily reduced NBT in response to parasite ingestion (Table I and Fig. 6B ), indicating no apparent defect in recognition of toxoplasmas.
ROLE OF OXYGEN INTERMEDIATES IN LYMPHOKINE HIB-INDUCED ANTITOXOPLASMA AC-
TIVITY. In contrast to the preceding lymphokine experiments, cocultivation with HIB and toxoplasma lymphokine for 18 h before infection renders normal macrophages as effective as IM cells in inhibiting parasite multiplication (13) . HIB alone has no effect. Although NBT reduction in response to toxoplasma ingestion was * Percent of macrophages with intracellular toxoplasmas or zymosan stained blue-black by formazan precipitation as in Fig. 6 . Results are the means ± SEM of three to four experiments, each in duplicate. Control supernates failed to enhance NBT reduction in response to toxoplasma ingestion. Results for PP-elicited cells were similar to thee shown in this table. The inclusion of SOD (1 mg/ml) with the parasites or particles decreased the percent of cells reducing NBT by a mean of 46% in two experiments. :~ Freshly explanted normal macrophages were cultivated in medium alone or medium plus lymphokine in the indicated concentrations for 72 h (media changed daily), and were then challenged for 30 rain with either 2 × 106 toxoplasmas or 2 × 106 opsonized zymosan particles suspended in medium containing NBT, 0.5 mg/ml. Uningested parasites or particles were removed by washing, and cultures were reincubated for an additional 30 min in medium alone.
Fro. 6. Bright field micrographs demonstrating qualitative NBT reduction by normal macro° phages 1 h after ingestion of toxoplasmas. Cells were cultivated for 72 h in medium alone (A) or medium plus 5% toxoplasma lymphokine (B), and then challenged with toxoplasmas suspended in 0.5 mg/ml NBT as described. Approximately one-third of the control cells in this field (A) have ingested parasites (short arrows), but only one shows a formazan-stained organism (long arrow). In contrast, most toxoplasmas ingested by lymphokine-stimulated cells (B) have provoked NBT reduction with formazan precipitation. Extracellular toxoplasmas did not reduce NBT, × 800. Also see Table I .
clearly e n h a n c e d in t r e a t e d cells ( T a b l e II), t h e r e w a s o n l y a 30% i n c r e a s e in O~-release a n d n o increase in e x t r a c e l l u l a r H 2 0 2 release a f t e r 1 8 -2 4 h of e x p o s u r e to H I B -l y m p h o k i n e ( d a t a n o t s h o w n ) . H o w e v e r , H I B w a s f o u n d to effectively s c a v e n g e H 2 0 2 in b o t h a cell-free H 2 0 2 -g e n e r a t i n g s y s t e m (Fig. 7 A) a n d in P M A -t r i g g e r e d , IB m a c r o p h a g e s (Fig. 7 B) . P P a n d T H I O also q u e n c h e d H 2 0 2 p r o d u c t i o n . In c o n t r a s t , H I B a n d T H I O were less effective s c a v e n g e r s of e n z y m a t i c a l l y g e n e r a t e d O~- (Fig.  7 A) , a Table I . Results are the means 3= SEM of four experiments, each performed in duplicate. :~ Freshly explanted normal macrophages were cultivated for 18 h in medium alone, medium plus HIB (8 mg/ml), or toxoplasma lymphokine (5%), or both agents together, Cells were then challenged and processed as in Table  I legend. Table III . The latter procedure reduces macrophage HzOz release (19) . Both SOD (for 02-) and catalase (for HzO2) effectively reversed inhibition of toxoplasma multiplication (Fig. 8) , suggesting a role for products of their interaction such as OH. and 102 (15, 16, 20) . OH. scavengers (mannitol, benzoate) and 102 quenchers (DABCO, histidine) (20) were also effective in inhibiting toxoplasmastatic activity. Thus, similar to our previous observations with in vivo activated macrophages (2), these findings indicate a role for oxidative metabolites in the antimicrobial activity induced by lymphokine. Freshly explanted normal macrophages were first cultivated for 18 h with HIB (8 mg/ml) and toxoplasma lymphokine (5%), and were then exposed to glucose-free medium or scavengers in the indicated concentrations 3 h before, during, and 24 h after infection (2). 5 mM glucose was added back to glucosedeprived ceils 2 h after infection (2) . Heated catalase and SOD did not reverse parasite inhibition (2) . Results are the means "4" SEM of (n) experiments each performed in duplicate.
n d a 4-h p r e i n c u b a t i o n w i t h 10 m g / m l H I B or T H I O r e d u c e d IB O~-release b y less t h a n 10% ( d a t a n o t s h o w n ) .
Fio. 8. Phase contrast micrographs of macrophages 24 h after infection. A. Inhibition of toxoplasma replication by normal macrophages cultivated 18 h before infection with HIB (8 mg/ml) and 5% toxoplasma lymphokine. B. Same macrophages after exposure to exogenous catalase (2 rag/ ml) as described in Table III legend. × 1,200.
Discussion
By q u a n t i t a t i v e l y c h a r a c t e r i z i n g the o x i d a t i v e c a p a c i t y o f a w i d e s p e c t r u m o f in vivo-a n d in v i t r o -s t i m u l a t e d m a c r o p h a g e p o p u l a t i o n s , we h a v e p r o v i d e d firm evid e n c e that t h e e n h a n c e d c a p a c i t y to g e n e r a t e o x y g e n i n t e r m e d i a t e s is a consistent m a r k e r that distinguishes a c t i v a t e d m a c r o p h a g e s from their u n s t i m u l a t e d or inflamm a t o r y counterparts. M o r e o v e r , the close relationship b e t w e e n H 2 0 2 release a n d t h e ability to act against T. gondii, an i n t r a c e l l u l a r o r g a n i s m susceptible to p r o d u c t s of O~--H202 i n t e r a c t i o n (1, 2), illustrates a clear biologic correlation for a u g m e n t e d oxidative m e t a b o l i s m in the a n t i m i c r o b i a l activity o f in vivo i m m u n o l o g i c a l l y acti-vated macrophages. This latter finding, however, does not necessarily apply to cells activated in vitro by lymphokine (see below).
Although macrophages elicited by inflammatory agents, such as THIO, PP, or starch, spread quickly on glass, phagocytize avidly, and demonstrate certain increased metabolic and secretory activities (21), they, like normal cells, fail to display the key protective properties of enhanced microbicidal or tumoricidal activity (5, (22) (23) (24) (25) . Our current findings indicate that augmented oxidative metabolism, which has been implicated in both eytocidal processes (2, 8, 17, 19) , is consistently not a feature of normal or inflammatory macrophages when compared with cells obtained after stimuli such as systemic BCG or toxoplasma infection or immunization with dead BCG or C. parvum. Thus, the ability to kill or inhibit intracellular toxoplasmas may be a useful in vitro biologic assay system by which both a heightened state of activation and an augmented oxidative capacity of in vivo-stimulated macrophages can be identified. Indeed, we have yet to encounter an in vivo activated, high HzO2-releasing macrophage that does not exert some antitoxoplasma activity. In addition to H202 and O~-release (6), mononuclear phagocyte oxidative activity has also been assessed recently by OH. formation (26) (27) (28) . The latter procedure would be particularly appropriate for studies investigating O~--and H202-resistant, but OH.-susceptible targets such as T. gondii (1, 2) .
After 48 h of cultivation in standard medium, IM and IB macrophages spontaneously lose their respective antitoxoplasma activities and fail to restrict parasite replication (2) . Because oxygen intermediates appear to mediate this activity (2), it was important to observe that macrophage oxidative capacity appropriately declined in a parallel fashion. Nathan et al. (29) have reported similar results with T. cruziimmune cells. Daily addition of fresh lymphokine, however, preserved both of these markers of IM and IB macrophage activation. Previous work has also indicated that soluble products of sensitized T lymphocytes (lymphokines) stimulate a variety of macrophage processes (30, 31) , including induction or enhancement of tumoricidal or antimicrobial activity (5, 10-14, 24, 32-34) and augmented oxidative metabolism (29) . In the latter study, macrophage release of H20~ correlated closely with the capacity to kill intracellular trypanosomes (29) . It should be pointed out, however, that although lymphokine maintained both the ability of IM and IB cells to release increased O~ and H202, and to inhibit parasite replication (toxoplasmastatic activity), it did not prevent the eventual loss of IB cells' toxoplasmacidal activity. This finding may reflect biologic deficiencies inherent with experimentally prepared lymphokines, loss of macrophage responsiveness to lymphokine, alteration in the generation or delivery of the key toxoplasmacidal oxygen intermediates (OH. and 102) (2), or perhaps atrophy of a synergistic but lymphokine-unresponsive microbicidal mechanism,
To explore in vitro activation of macrophages, we attempted to induce resident and inflammatory (PP) cells to display antitoxoplasma activity by exposing them to mitogen-and antigen-stimulated supernates both before and after infection. In similar models, resident and elicited macrophages from normal mice can be induced to eradicate the intracellular parasites, L. enrietti (14) and T. cruzi (5) . As reported by others (5, 29), we too found that lymphokine exposure morphologically activates resident and PP cells and, in parallel, augments O~-and H202 release. However, in contrast to the other parasite-macrophage models, lymphokine-activated cells failed to kill or inhibit the replication of intracellular toxoplasmas. This dissociation of enhanced oxidative capacity from antimicrobial activity was further emphasized by the finding that in vitro-activated cells released as much O~-and H202 as in vivoactivated macrophages. The latter readily inhibited parasite multiplication (Fig. 1) . As judged by enhanced intracellular NBT reduction (8, 9) , there was no failure on the part of lymphokine-treated cells to generate O~-in response to toxoplasrna ingestion. This was important to investigate because T. gondii avoids triggering the oxidative respiratory burst of macrophages that permit toxoplasma replication (8) .
The formation of OH. and 102, both of which appear to be toxoplasmacidal (1, 2), seems to depend upon the initial interaction of O~-and H~O2 in the presence of trace metal (iron) ions (15, 16, 20) . Thus, OH-generation and resultant antitoxoplasma activity would be anticipated by O~--and H202-releasing in vitro-activated cells. However, as shown in the accompanying report (35) , these macrophages contain high activity of endogenous O2-and H~O~ scavenging mechanisms (SOD, eatalase, glutathione peroxidase) that may interfere with OH. or 102 production within or delivery to the phagocytic vacuole. Such mechanisms might theoretically not affect the microbicidal activity of lymphokine-activated, H202-releasing cells toward an H202-susceptible parasite such as T. cruzi (29) .
The HIB-lymphokine system, which sufficiently activates normal cells in vitro to inhibit toxoplasma replication, permitted assessment of the role of oxygen intermediates in lymphokine-mediated enhancement of antiprotozoal activity. The molecular basis underlying the synergistic action of HIB and lymphokines has not been investigated, but may be related to the presence of endotoxin (36) . Thus, in this system, HIB can be replaced by endotoxin (13) , as well as THIO (13) or PP, and BCG and Con A supernates can substitute for toxoplasma lymphokine (H. Murray. Unpublished observations). Although there was only a small increase in extracellular O~-release and no increase in H202 release after HIB-lymphokine exposure (presumably related to the broad scavenging effects of HIB), intracellular oxidative activity was clearly enhanced as judged by NBT reduction in response to toxoplasma ingestion (8) . Furthermore, exogenous scavengers and quenchers of O~-, H202, OH., and 102 and glucose deprivation all inhibited the toxoplasmastatic activity of HIB-lymphokine-treated macrophages. These results, which are similar to our previous findings with IM and IB cells (2) , clearly demonstrate the presence and activity of an oxygendependent system beyond the production of O2-and H202 in macrophages activated in vitro by lymphokines.
In the course of this study, we also investigated the conflicting data surrounding the oxidative capacity of THIO-elicited macrophages that, like normal cells, fail to inhibit toxoplasma replication. Johnston et al. (6) reported that, after PMA triggering, cultivated THIO macrophages release O~-in amounts comparable with those from BCG-infected and -boosted mice, and 10-fold more than normal resident macrophages. In contrast, others have found little O~-(37) or H202 (3) release from freshly harvested THIO cells in suspension. In our hands, after overnight cultivation these macrophages showed intermediate results with a twofold increase in O~-release (0.12 :1:0.02 nmol//Lg protein), but no increase in H202 release compared with normal cells. THIO macrophages also generated fourfold less O~-than cells from IB mice. Interestingly, THIO was found to be a much more effective scavenger of H202 than O~-, which may explain in part these disparate results. Nathan and Cohn (38) have also recently shown that THIO both inhibits activated macrophages' H202 release and antitumor cell activity, an H2Oz-dependent process. In addition, although the intracellular catalase levels of THIO, resident, and IB are comparable after 24 h of cultivation, THIO cells contain 50% less SOD and 1.5-to 2.5-fold more gtutathione peroxidase (35) , thus raising the possibilities of both diminished formation of H202 from O2-and/or enhanced H202 decomposition by the reduced glutathione pathway. The potentially important role played by the enzymatic oxygen intermediates scavengers, SOD, catalase, and glutathione peroxidase, which are present within both 72.
gondii and activated macrophages, is examined in the accompanying report.
Summary
The capacity of 15 separate populations of mouse peritoneal macrophages to generate and release H202 (an index of oxidative metabolism) was compared with their ability to inhibit the intracellular replication of virulent Toxoplasma gondii.
Resident macrophages and those elicited by inflammatory agents readily supported toxoplasma multiplication and released 4-20× less H202 than macrophages activated in vivo by systemic infection with Bacille Calmette-Gu6rin or T. gondii, or by immunization with Co~ynebacterium parvum. Immunologically activated cells consistently displayed both enhanced H202 production and antitoxoplasma activity. Exposure to lymphokines generated from cultures of spleen cells from T. gondii immune mice and toxoplasma antigen preserved both the antitoxoplasma activity and the heightened H202 release of toxoplasma immune and immune-boosted macrophages, which otherwise were lost after 48-72 h of cultivation.
In vitro activation of resident and chemically-elicited cells by 72 h of exposure to mitogen-and antigen-prepared lymphokines, conditions that induce trypanocidal (5) and leishmanicidal activity (14) , stimulated O2-and H~O2 release, and enhanced nitroblue tetrazolium reduction in response to toxoplasma ingestion. Such treatment, however, failed to confer any antitoxoplasma activity, indicating that intracellular pathogens may vary in their susceptibility to macrophage microbicidal mechanisms, including specific oxygen intermediates. In contrast, cocultivating normal macrophages with lymphokine plus heart infusion broth for 18 h rendered these cells toxoplasmastatic. This in vitro-acquired activity was inhibited by scavengers of O~: H202, OH., and 102, demonstrating a role for oxidative metabolites in lymphokineinduced enhancement of macrophage antimicrobial activity.
These findings indicate that augmented oxidative metabolism is a consistent marker of macrophage activation, and that oxygen intermediates participate in the resistance of both in vivo-and in vitro-activated macrophages toward the intracellular parasite, 72. gondii.
